Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Heien

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|July 28, 2007
Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapyAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
The American Journal of Managed Care|August 10, 2007
Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimenAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
Gastrointestinal Endoscopy|January 17, 2016
Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohortRajesh Krishnamoorthi, Bijan Borah, Herbert Heien, et al.
Expert Opinion on Pharmacotherapy|March 19, 2008
Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual careCarolyn R Harley, Sanjay K Gandhi, Herbert Heien, et al.
Gastrointestinal Endoscopy|January 17, 2017
ResponseRajesh Krishnamoorthi, Bijan Borah, Herbert Heien, et al.
The American Journal of Geriatric Pharmacotherapy|November 13, 2007
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practiceCarolyn R Harley, Sanjay Gandhi, James Blasetto, et al.
Journal of Surgical Oncology|January 26, 2021
Cost drivers of locally advanced rectal cancer treatment-An analysis of a leading healthcare insurerFabian Grass, Amit Merchea, Kellie L Mathis, et al.
BMJ (Clinical Research Ed.)|April 26, 2015
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort studyNeena S Abraham, Sonal Singh, G Caleb Alexander, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Patients With Inflammatory Bowel Disease Are at Increased Risk for Complications of Herpes ZosterFreddy Caldera, Siddharth Singh, Emily E Zona, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|July 28, 2007
Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapyAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
The American Journal of Managed Care|August 10, 2007
Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimenAylin A Riedel, Herbert Heien, Jenifer Wogen, et al.
Gastrointestinal Endoscopy|January 17, 2016
Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohortRajesh Krishnamoorthi, Bijan Borah, Herbert Heien, et al.
Expert Opinion on Pharmacotherapy|March 19, 2008
Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual careCarolyn R Harley, Sanjay K Gandhi, Herbert Heien, et al.
Gastrointestinal Endoscopy|January 17, 2017
ResponseRajesh Krishnamoorthi, Bijan Borah, Herbert Heien, et al.
The American Journal of Geriatric Pharmacotherapy|November 13, 2007
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practiceCarolyn R Harley, Sanjay Gandhi, James Blasetto, et al.
Journal of Surgical Oncology|January 26, 2021
Cost drivers of locally advanced rectal cancer treatment-An analysis of a leading healthcare insurerFabian Grass, Amit Merchea, Kellie L Mathis, et al.
BMJ (Clinical Research Ed.)|April 26, 2015
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort studyNeena S Abraham, Sonal Singh, G Caleb Alexander, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Patients With Inflammatory Bowel Disease Are at Increased Risk for Complications of Herpes ZosterFreddy Caldera, Siddharth Singh, Emily E Zona, et al.
Pageof 1